{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:12:14Z","timestamp":1794305534711,"version":"4.9.0"},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treatment for both facial and truncal acne has not sufficiently been studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the long\u2010term safety and efficacy of trifarotene in both facial and truncal acne.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In a multicentre, open\u2010label, 52\u2010week study, patients with moderate facial and truncal acne received trifarotene 50\u00a0\u03bcg\/g cream (trifarotene). Assessments included local tolerability, safety, investigator and physician's global assessments (\n                      <jats:styled-content style=\"fixed-case\">IGA<\/jats:styled-content>\n                      ,\n                      <jats:styled-content style=\"fixed-case\">PGA<\/jats:styled-content>\n                      ) and quality of life (\n                      <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content>\n                      ). A validated\n                      <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content>\n                      questionnaire was completed by the patient at Baseline, Week 12, 26 and 52\/\n                      <jats:styled-content style=\"fixed-case\">ET<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 453 patients enrolled, 342 (75.5%) completed the study. Trifarotene\u2010related treatment\u2010emergent adverse events (\n                      <jats:styled-content style=\"fixed-case\">TEAE<\/jats:styled-content>\n                      s) were reported in 12.6% of patients, and none was serious. Most related\n                      <jats:styled-content style=\"fixed-case\">TEAE<\/jats:styled-content>\n                      s were cutaneous and occurred during the first 3\u00a0months. Signs and symptoms of local tolerability were mostly mild or moderate and severe signs, and symptoms were reported for 2.2% to 7.1% of patients for the face and 2.5% to 5.4% for the trunk. Local irritation increased during the first week of treatment on the face and up to Weeks 2 to 4 on the trunk with both decreasing thereafter.\n                    <\/jats:p>\n                    <jats:p>\n                      At Week 12,\n                      <jats:styled-content style=\"fixed-case\">IGA<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">PGA<\/jats:styled-content>\n                      success rates were 26.6% and 38.6%, respectively. Success rates increased to 65.1% and 66.9%, respectively at Week 52. Overall success (both\n                      <jats:styled-content style=\"fixed-case\">IGA<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">PGA<\/jats:styled-content>\n                      success in the same patient) was 57.9% at Week 52.\n                    <\/jats:p>\n                    <jats:p>\n                      At Week 52 visit, 92\/171 (53.8%) patients who had completed their assessments had scores from 0 to 1 (i.e. no effect of acne on their\n                      <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content>\n                      ) vs. 47\/208 (22.6%) patients at Baseline visit.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this 52\u2010week study, trifarotene was safe, well tolerated and effective in moderate facial and truncal acne.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jdv.15794","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T16:23:09Z","timestamp":1563207789000},"page":"166-173","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Long\u2010term safety and efficacy of trifarotene 50\u00a0\u03bcg\/g cream, a first\u2010in\u2010class\n                    <scp>RAR<\/scp>\n                    \u2010\u03b3 selective topical retinoid, in patients with moderate facial and truncal acne"],"prefix":"10.1111","volume":"34","author":[{"given":"U.","family":"Blume\u2010Peytavi","sequence":"first","affiliation":[{"name":"Department of Dermatology and Allergy Charit\u00e9\u2010Universit\u00e4tsmedizin Berlin Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fowler","sequence":"additional","affiliation":[{"name":"Division of Dermatology University of Louisville Louisville KY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kem\u00e9ny","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy University of Szeged Szeged Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Draelos","sequence":"additional","affiliation":[{"name":"Dermatology Consulting Services PLLC High Point NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cook\u2010Bolden","sequence":"additional","affiliation":[{"name":"Skin Specialty Dermatology New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Dirschka","sequence":"additional","affiliation":[{"name":"Centroderm Clinic Wuppertal Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Eichenfield","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics University of California San Diego School of Medicine and Rady Children's Hospital San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Graeber","sequence":"additional","affiliation":[{"name":"Galderma Research and Development LLC Fort Worth TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Galderma Research and Development LLC Fort Worth TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ali\u00f3 Saenz","sequence":"additional","affiliation":[{"name":"Galderma Research and Development LLC Fort Worth TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rich","sequence":"additional","affiliation":[{"name":"Oregon Dermatology and Research Portland OR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tanghetti","sequence":"additional","affiliation":[{"name":"Center for Dermatology and Laser Surgery Sacramento CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13462"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)80056-5"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2001.00357.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2010.2722"},{"key":"e_1_2_6_6_1","first-page":"22","article-title":"Understanding the burden of adult female acne","volume":"7","author":"Tanghetti EA","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.12.037"},{"key":"e_1_2_6_8_1","first-page":"551","article-title":"Prevalence and severity of facial and truncal acne in a referral cohort","volume":"7","author":"Tan JK","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_9_1","first-page":"285","article-title":"Management of truncal acne vulgaris: current perspectives on treatment","volume":"77","author":"Rosso JQ","year":"2006","journal-title":"Cutis"},{"key":"e_1_2_6_10_1","first-page":"321","article-title":"Chest and back acne: a retrospective review","volume":"12","author":"Mandy S","year":"1995","journal-title":"Adv Ther"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-017-0185-2"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13776"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.09.078"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16719"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.04.036"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.d01-1169.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb16953.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000051381"},{"issue":"6","key":"e_1_2_6_19_1","first-page":"s24","article-title":"Long\u2010term safety and efficacy study of adapalene 0.3% gel","volume":"7","author":"Weiss JS","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_20_1","first-page":"530","article-title":"Tolerability of topical retinoids: are there clinically meaningful differences among topical retinoids?","volume":"19","author":"Culp L","year":"2015","journal-title":"J CutMed Surg"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16733"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2012.751085"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2003.02037.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.044"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.15794","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.15794","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.15794","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.15794","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:31:36Z","timestamp":1791282696000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.15794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1111\/jdv.15794"],"URL":"https:\/\/doi.org\/10.1111\/jdv.15794","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,20]]},"assertion":[{"value":"2018-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}